Clincosm LogoSign in Get a demo

stage iv breast cancer

Showing 76 - 100 of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in New York (ganetespib, paclitaxel, trastuzumab)

Completed
  • HER2-positive Breast Cancer
  • +6 more
  • New York, New York
  • +1 more
Jun 13, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Tampa (biological, drug, other)

Completed
Has Results
  • Male Breast Cancer
  • +3 more
  • adenovirus-p53 transduced dendritic cell (DC) vaccine
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 14, 2018

Stage IV Breast Cancer Trial in Sacramento (radiation, drug, other)

Completed
  • Stage IV Breast Cancer
  • carbon C 14 oxaliplatin
  • +2 more
  • Sacramento, California
    UC Davis Comprehensive Cancer Center
Jan 5, 2018

Male Breast Cancer, Recurrent Breast Cancer, Skin Metastases Trial in Seattle (drug, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Dec 7, 2017

HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)

Terminated
Has Results
  • HER2-negative Breast Cancer
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2017

Estrogen Receptor Positive, Male Breast Carcinoma, Progesterone Receptor Positive Trial in Detroit (Laboratory Biomarker

Completed
Has Results
  • Estrogen Receptor Positive
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Detroit, Michigan
  • +1 more
Oct 27, 2017

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer Trial in Seattle (HER-2/neu Intracellular Domain Protein,

Unknown status
  • HER2/Neu Positive
  • +2 more
  • HER-2/neu Intracellular Domain Protein
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 27, 2017

Stage IV Breast Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
  • Stage IV Breast Cancer
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Sep 26, 2017

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer Trial in Seattle (drug,

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • doxorubicin hydrochloride
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2017

Adult Solid Tumor, Recurrent Breast Carcinoma, Stage IV Breast Cancer Trial in Boston, Nashville, Houston (Akt Inhibitor MK2206,

Completed
  • Adult Solid Neoplasm
  • +2 more
  • Akt Inhibitor MK2206
  • +3 more
  • Boston, Massachusetts
  • +2 more
Aug 24, 2017

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer - BRCA1 Trial in Seattle

Completed
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 8, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (pegylated liposomal doxorubicin HCl,

Completed
Has Results
  • HER2-positive Breast Cancer
  • +3 more
  • pegylated liposomal doxorubicin hydrochloride
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 27, 2017

Recurrent Breast Carcinoma, Stage IV Breast Cancer Trial in San Francisco, New York (biological, drug, other)

Completed
Has Results
  • Recurrent Breast Carcinoma
  • Stage IV Breast Cancer
  • Bevacizumab
  • +2 more
  • San Francisco, California
  • +1 more
Jun 23, 2017

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer Trial in Seattle

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +7 more
  • tamoxifen citrate
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/Puget Sound Oncology Cons
Jun 16, 2017

CNS Metastases, Leptomeningeal Metastases, Recurrent Breast Cancer Trial in Seattle (methotrexate, liposomal cytarabine,

Completed
Has Results
  • Central Nervous System Metastases
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 7, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
Has Results
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (biological, procedure, drug, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +3 more
  • HER-2/neu peptide vaccine
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer Trial in Seattle (Laboratory Biomarker Analysis,

Completed
  • HER2/Neu Positive
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 19, 2017

Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Recurrent Breast Cancer Trial (breast reconstruction,

Withdrawn
  • Ductal Breast Carcinoma in Situ
  • +9 more
  • breast reconstruction
  • intraoperative imaging
  • (no location specified)
Apr 12, 2017

Musculoskeletal Complication, Recurrent Breast Carcinoma, Stage IA Breast Cancer Trial in Los Angeles (Quality-of-Life

Terminated
  • Musculoskeletal Complication
  • +10 more
  • Quality-of-Life Assessment
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Apr 11, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine)

Terminated
  • HER2-positive Breast Cancer
  • +3 more
  • HER-2/neu peptide vaccine
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 9, 2017

Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer Trial in United States (biological, drug, other)

Terminated
Has Results
  • Breast Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Jonesboro, Arkansas
  • +372 more
Dec 12, 2016

Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Saint Louis (BKM120,

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2017

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer Trial in Detroit (tanespimycin, laboratory biomarker

Terminated
Has Results
  • Recurrent Breast Cancer
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 18, 2016